Spermosens AB reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was SEK 3.95 million compared to SEK 1.55 million a year ago. Revenue was SEK 3.96 million compared to SEK 1.55 million a year ago. Net loss was SEK 2.54 million compared to SEK 0.89 million a year ago. Basic loss per share from continuing operations was SEK 0.24 compared to SEK 0.17 a year ago.